We have studied the lac repressor (lacR) system in two breast cancer cell lines, in vitro 
INTRODUCTION
There are several systems for controlling gene induction in mammalian cells. Naturally occurring promoters that are themselves inducible by external stimuli have been used; for example, metallothionein promoter (15), heat-shock promoters (13) and mouse mammary tumor virus promoter (16) . The pitfall with these systems is that they are generally "leaky" under noninduced conditions, have only small to modest levels of induction and the inducers of these promoters have biologic effects within the cells. Two recently reported inducible systems, the tetracycline (6) and ecdysone (11) expression systems, show high levels of induction in mammalian cells and animals. While both systems allow induction of up to 1000-fold, both can have high basal expression, which is undesirable for expression of toxic or growth-inhibitory genes.
The lac repressor system has been developed from the prokaryotic lac operon (2) , where lac repressor (lacR) binds as a homotetramer to a sequence called the lac operator in the promoter of the β -galactosidase ( β -gal) gene. Binding of allolactose, or the synthetic inducer isopropyl β -D -thiogalactoside (IPTG), lowers the affinity of lacR for the operator sequence (1), thereby allowing transcription. This system of inducible expression has been adapted for mammalian cells (3, 7) and has a number of advantages over other systems. First, there are probably no lac operator sequences within regulatory sequences of eukaryotic promoters. Second, and most important in the control of toxic gene expression, the system involves a relief of repression of transcription rather than an induction of a basal level of transcription, so that basal expression remains low.
Several genes in different cell types have been expressed under the control of the lac repressor system including Ha-ras (10), simian virus 40 (SV40)-T antigen (4), growth hormone (8) and human adrenergic receptor (5) . Transgenic animals have been generated that express both lacR and SV40 large T antigen (lacO) under the control of lac operator sequences (4); however, a complete repression of transcription was not seen. Wyborski et al. (17) created transgenic mice expressing both lacR and lac operator/luciferase reporter constructs; however, IPTG caused no increase in reporter gene expression either in the animal or in primary cultured cells.
Here, we show how the lac repressor system can be used in controlling gene expression in two breast cancer cell lines in vitro. Induction is rapid, reversible and dose-responsive. Additionally we have shown that the lac repressor system can be used to control in vivo inducible gene expression in breast cancer grown as a xenograft tumor in nude mice.
MATERIALS AND METHODS

Plasmids
The LacSwitch ™ Mammalian Inducible Expression System was purchased from Stratagene (La Jolla, CA, USA). A multiple cloning site (MCS) was introduced into the unique Not I site of pOPRSVCAT by ligating the oligonucleotides listed in Table 1 , which thereby remove the chloramphenicol acetyl transferase ( cat ) gene. The resulting plasmid (pOPRSVMCS) was sequenced to determine orientation of the MCS. pOPRSVLuc was generated by digesting the luciferase gene from pGLBasic with Xho I/ BamHI and ligating this fragment into the Xho I/ Bcl I sites of pOPRSV.
Cell Culture and Transfection
MCF-7 cells were originally obtained from Dr. C.K. Osborne (12) . MDA-MB-231 cells (Clone 10A) were kindly provided by Dr. V.C. Jordan (9) . Cells were routinely maintained in improved minimal essential medium (IMEM), 10% fetal bovine serum (FBS), 2 mM glutamine, 50 I.U./mL penicillin and 5 µ g/mL streptomycin. 
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lac-operator containing Rous sarcoma virus [RSV] promoter upstream of luciferase). Both plasmids contain both the gene of interest and an antibiotic resistance gene, thus we only transfected a single plasmid at each step. Stable transfectants for LacR (p3 ′ SS) were selected in hygromycin (MCF-7, 200 µ g/mL; MDA-MB-231, 600 µ g/mL) and for luciferase (pOPRSVLuc) in G418S (MCF-7, 600 µ g/mL; MDA-MB-231, 1200 µ g/mL).
Western Blotting
Cells were grown to sub-confluence in 10-cm dishes and lysed with 5% sodium dodecyl sulfate (SDS). DNA was sheared by sonication (2 × 5 s), and protein concentration was determined by the BCA Protein Assay (Pierce Chemical, Rockford, IL, USA). Equal amounts of protein were separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE) and electrophoresed onto nitrocellulose overnight at 4°C. After blocking in 5% milk-TBST (0.15 M NaCl, 0.01 M Tris-HCl, pH 7.4, 0.05% Tween ® 20) for 1 h, membrane was washed three times with TBST and then incubated with a 1:1000 dilution of anti-lacR antibody (Stratagene) in 5% milk-TBST. After another three washes with TBST, antibody was detected with a 1:1000 dilution of horseradish peroxidase (HRP)-linked goat anti-rabbit antibody and enhanced chemiluminesence (ECL ™;Amersham, Arlington, IL, USA). M15 bacteria (Qiagen, Chatsworth, CA, USA) that express lacR were used as a positive control.
In Vivo Growth of MDA-rep4luc2
Cells MDA-rep4luc2 cells were grown in the mammary fat pad of the nude mouse. Briefly, mice were injected with 2 × 10 7 cells, and the tumors were allowed to grow to a size of approximately 7 × 7 mm. At time 0, the mice were anesthetized, biopsies of the tumors were taken with a 14-g PrecisionCut needle (Becton Dickinson, Franklin Lakes, NJ, USA) and the core biopsy was frozen immediately in liquid nitrogen. Mice were then injected intraperitoneally with 200 µ L IPTG (0.53 mmol). Mice were re-injected after 4 h, and then biopsies were performed at the following time points (8, 
RESULTS
Expression of lacR Repressor and IPTG Induction in Breast Cancer Cells
Two breast cancer cells lines (MCF-7 and MDA-MB-231) were transfected with lacR, and expression was analyzed by Western blotting (Figure 1 
IPTG Induction is Dose-Responsive
MDA-rep4luc 2 cells were incubated with increasing concentrations of IPTG (0-1 mM) for 24 h, and luciferase activity was determined (Figure 2) . IPTG caused a dose-dependent increase in luciferase activity, with half-maximal induction at ca. 20 µ M of inducer. As expected, 1 mM IPTG, which was used in the previous experiment, was a saturating concentration for induction.
IPTG Induction is Rapid and Reversible
IPTG caused a rapid induction of luciferase activity in MDA-rep4luc2 cells (Figure 3) . Induction was seen as early as 1 h and reached a maximum of 40-fold induction after 24 h. The increase in luciferase activity could be reversed by removing the IPTG from the media. We consistently observed a transient increase in luciferase activity after removal of IPTG; however, this increase only lasted for 4 h, and the decrease in activity was then rapid-returning to basal level after 24 h.
In Vivo Induction of Luciferase Activity
MDA-rep4luc2 cells (2 × 10 7 ) were injected into the mammary fat pad of nude mice. When the tumor had 1066BioTechniques
Vol. 23, No. 6 (1997) reached a size of 7 × 7 mm (after approximately 3 weeks), the tumors were biopsied. Mice were injected intraperitonealy at 1 and 4 h with IPTG (0.53 mmol), and luciferase activity was measured by biopsying the tumors at time points thereafter. IPTG caused a rapid induction in luciferase activityreaching 10-fold after 24 h (Figure 4) . Interestingly, activity higher than baseline was still detectable up to 72 h after IPTG injection. As luciferase protein has a short half-life of 3-4 h (14), this presumably represents continued luciferase gene transcription.
DISCUSSION
Tightly controlled inducible gene expression provides a mechanism for the study of toxic or growth-inhibitory genes in cancer cells. This paper describes the introduction and characterization of the lac repressor system into two breast cancer cell lines (MCF-7 and MDA-MB-231). The system provides a high level of rapid and reversible gene induction, with low basal expression provided by a bacterial protein, lacR. Compared with the tetracycline or ecdysone inducible systems, the lacswitch system is fairly simple. Only a single protein needs to be expressed (lacR) to confer inducibility. However, it is clear from our data that simple expression of lacR does not necessarily confer inducibility. This indicates the importance of first transfecting lacR and analyzing clones before stable tansfection with the lac operator plasmid. Simple double transfection with both plasmids will generate a number of clones that fail to show inducibilty even though they express lacR. Although expression and targeting to the nucleus has been shown to inhibit transcription of genes engineered with lac operator sequences in the promoter (3), our transfection studies suggest that localization or posttranslational modification of lacR may be important in its ability to cause repression.
One of the major advantages of this system is the ability to produce cells with low levels of basal expression; however, in our breast cancer cells, the absolute values of luciferase activity and mRNA expression (data not shown) were low. This is probably due to low activity of the RSV promoter compared with other promoters (cytomegalovirus [CMV]) or SV40). The RSV promoter may be substituted with a more active promoter; however, we do not know at present if this will affect the resulting basal activity.
In vivo applications of the lac repressor system include gene therapy, antisense mRNA expression, overexpression of toxic or teratogenic genes, etc. One of the advantages of the lac re -pressor system is the rapid uptake of the inducer (IPTG) by mammalian cells. In vitro data presented here show a rapid and reversible induction of gene expression. However, this represents one of the possible setbacks of using this system in vivo. Wyborski et al. (18) studied the pharmacokinetics of IPTG in mice, with respect to using the lac repressor system in animals. IPTG was taken up rapidly by all tissues, but had a short half-life (30 min). We used this information to analyze the in vivo induction of gene expression in MDA-MB-231 cells grown as a flank tumor in nude mice. Injection of a maximal dose of IPTG (0.53 mmol) resulted in a 10-fold increase in luciferase activity within the tumor, suggesting that this system will allow tightly controlled gene expression in vivo. Interestingly, continued expression of luciferase was seen up to 72 h. As luciferase protein has a short half-life of 3-4 h, we conclude that ongoing transcription and translation may be occurring. This suggests that even though IPTG is rapidly removed from the circulation (half-life of 30 min), it may affect the tumor cells for a longer period of time. While 72 h of expression may be sufficient to study some genes in vivo, it is not clear how long the relief of repression can be maintained.
Thus, the system allows for essentially nil levels of gene expression in the absence of inducer. Both in vitro and in vivo gene induction, albeit at low levels, can be acheived with IPTG.
